Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de James B Weissman. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que James B Weissman reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
Director 8,390
US:DRNA / Dicerna Pharmaceuticals Inc Chief Operating Officer & EVP 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por James B Weissman. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por James B Weissman conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2024-07-26 2024-07-24 4 TBIO Telesis Bio Inc.
Common Stock
A - Award 8,390 8,390
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -68,100 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -121,300 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -75,000 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -111,800 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -180,000 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -105,000 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -33,999 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -11,879 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -11,325 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -25,950 0 -100.00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
U - Other -18,100 0 -100.00 38.25 -692,325
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -3,775 11,325 -25.00
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -1,675 18,100 -8.47 38.05 -63,734 688,705
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 3,775 19,775 23.59
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -30,000 33,999 -46.88
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -30,000 16,000 -65.22 39.09 -1,172,700 625,440
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 30,000 46,000 187.50 9.09 272,700 418,140
2021-04-20 2021-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,904 16,000 -23.46 29.99 -147,071 479,840
2021-02-08 2021-02-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7,156 20,904 -25.50 26.99 -193,140 564,199
2021-01-13 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5,808 28,060 -17.15 24.08 -139,868 675,741
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 68,100 68,100
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 15,100 15,100
2021-01-12 2021-01-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3,800 33,868 -10.09 23.99 -91,162 812,493
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -8,650 25,950 -25.00
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -2,842 37,668 -7.02 23.29 -66,190 877,288
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8,650 40,510 27.15
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 0 -100.00
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 31,860 -12.04 25.21 -109,903 803,098
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 36,220 13.68 3.42 14,911 123,872
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 4,360 -50.00
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 31,860 -12.04 20.95 -91,333 667,403
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 36,220 13.68 3.42 14,911 123,872
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10,000 11,879 -45.71
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10,000 31,860 45.75 2.97 29,700 94,624
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8,720 8,720 -50.00
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8,720 21,860 -28.52 20.20 -176,144 441,572
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8,720 30,580 39.89 3.42 29,822 104,584
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 25,980 -14.37
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1,307 21,860 -5.64 26.87 -35,116 587,330
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3,053 23,167 -11.64 26.39 -80,563 611,333
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -259 17,440 -1.46
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,101 21,879 -15.79
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1,432 21,860 -6.15 22.80 -32,649 498,393
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2,928 23,292 -11.17 22.31 -65,330 519,691
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 259 26,220 1.00 3.42 886 89,672
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,101 25,961 18.76 2.97 12,180 77,104
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 25,980 -14.37
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1,307 21,860 -5.64 26.87 -35,116 587,330
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3,053 23,167 -11.64 26.39 -80,563 611,333
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 30,340 -12.56
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 21.06 -91,807 460,299
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise 4,360 34,700 14.37
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 20.20 -88,072 441,572
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 39,060 -10.04
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 20.20 -88,072 441,572
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 43,420 -9.13
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 20.61 -89,854 450,506
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,360 47,780 -8.36
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 20.20 -88,072 441,572
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,360 26,220 19.95 2.97 12,949 77,873
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 121,300 121,300
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 34,600 34,600
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2,860 52,140 -5.20
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -1,500 0 -100.00
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4,360 21,860 -16.63 21.88 -95,376 478,194
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2,860 26,220 12.24 2.97 8,494 77,873
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 1,500 23,360 6.86 3.42 5,130 79,891
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -11,001 63,999 -14.67
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -3,845 21,860 -14.96 26.01 -100,008 568,579
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11,001 25,705 74.82 9.09 99,999 233,658
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20,000 55,000 -26.67
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20,000 14,704 -57.63 26.00 -520,000 382,304
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20,000 34,704 136.02 2.97 59,400 103,071
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20,000 14,704 -57.63 24.00 -480,000 352,896
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20,000 34,704 136.02 3.42 68,400 118,688
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20,000 20,000 -50.00
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20,000 14,704 -57.63 22.00 -440,000 323,488
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20,000 34,704 136.02 3.42 68,400 118,688
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20,000 40,000 -33.33
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20,000 14,704 -57.63 20.00 -400,000 294,080
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20,000 34,704 136.02 3.42 68,400 118,688
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15,000 17,699 -45.87
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15,000 14,704 -50.50 18.00 -270,000 264,672
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15,000 29,704 102.01 3.42 51,300 101,588
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4,104 60,000 -6.40
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -800 0 -100.00
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4,104 14,704 38.72 3.42 14,036 50,288
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 800 10,600 8.16 3.42 2,736 36,252
2019-08-23 2019-08-23 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -14,680 9,800 -59.97 13.07 -191,832 128,062
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15,000 32,699 -31.45
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15,000 24,480 -37.99 15.00 -225,000 367,200
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15,000 39,480 61.27 3.42 51,300 135,022
2019-01-04 2019-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 180,000 180,000
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2,301 47,699 -4.60
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2,301 24,480 -8.59 17.50 -40,268 428,400
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2,301 26,781 9.40 3.42 7,869 91,591
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -14,680 64,104 -18.63
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 14,680 24,480 149.80 3.42 50,206 83,722
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10,000 50,000 -16.67
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10,000 9,800 -50.51 15.00 -150,000 147,000
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10,000 19,800 102.04 3.42 34,200 67,716
2018-04-24 2018-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8,965 9,800 -47.78 13.00 -116,545 127,400
2018-03-21 2018-03-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1,035 18,765 -5.23 13.00 -13,455 243,945
2018-01-08 2018-01-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 105,000 105,000
2017-01-05 2017-01-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75,000 75,000
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 4,170 19,800 26.68 3.29 13,719 65,140
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 530 15,630 3.51 3.29 1,744 51,418
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 300 15,100 2.03 3.24 972 48,922
2016-01-12 2016-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75,000 75,000
2015-01-13 2015-01-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75,000 75,000
2014-04-18 2014-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 111,800 111,800
2014-02-20 2014-01-29 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 1,000 13,116 8.25 15.00 15,000 196,740
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -67 800 -7.73
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -11,216 78,784 -12.46
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11,283 12,116 1,354.50 3.24 36,557 39,256
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -100 1,500 -6.25
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -733 867 -45.81
2014-02-20 2013-11-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 833 833 3.42 2,849 2,849
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 90,000 90,000
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 60,000 60,000
2014-01-29 3 DRNA Dicerna Pharmaceuticals Inc
Common Stock
12,116
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)